We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$24.5B
AUM Growth
+$4.37B
Cap. Flow
+$2.47B
Cap. Flow %
10.08%
Top 10 Hldgs %
39.35%
Holding
397
New
164
Increased
36
Reduced
47
Closed
100

Sector Composition

Rank Sector Weight
1 Healthcare 29.51%
2 Technology 16.43%
3 Financials 13.12%
4 Communication Services 9.43%
5 Industrials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPVA.U
351
DELISTED
InterPrivate II Acquisition Corp. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
IPVA.U
-400,000
Closed -$3.96M
REVHU
352
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
-2,000,000
Closed -$20.1M
NDACU
353
DELISTED
NightDragon Acquisition Corp. SCALE Units
NDACU
-400,000
Closed -$4.08M
TMAC.U
354
DELISTED
The Music Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
TMAC.U
-125,000
Closed -$1.25M
AUS.U
355
DELISTED
Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
AUS.U
-500,000
Closed -$5.02M
FVIV.U
356
DELISTED
Fortress Value Acquisition Corp. IV Units, each consisting of one share of Class A common stock and one-eighth of one redeemable Warrant
FVIV.U
-1,750,000
Closed -$17.3M
ASZ.U
357
DELISTED
Austerlitz Acquisition Corporation II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
ASZ.U
-1,500,000
Closed -$15M
CFVIU
358
DELISTED
CF Acquisition Corp. VI Unit
CFVIU
-100,000
Closed -$990K
ASPCU
359
DELISTED
Alpha Capital Acquisition Co Unit
ASPCU
-79,598
Closed -$792K
ACTDU
360
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
-750,000
Closed -$7.5M
VGII.U
361
DELISTED
Virgin Group Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth
VGII.U
-1,000,000
Closed -$9.93M
TWNT.U
362
DELISTED
Tailwind Two Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of
TWNT.U
-1,000,000
Closed -$9.88M
SPAQ.U
363
DELISTED
Spartan Acquisition Corp. III Units, each consisting of one share of Class A common stock and one-fo
SPAQ.U
-60,053
Closed -$602K
SNII.U
364
DELISTED
Supernova Partners Acquisition Company II, Ltd. Units, each consisting of one Class A ordinary share
SNII.U
-200,000
Closed -$2.01M
NXU.U
365
DELISTED
Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi
NXU.U
-700,000
Closed -$7M
GMIIU
366
DELISTED
Gores Metropoulos II, Inc. Unit
GMIIU
-750,000
Closed -$7.59M
VPCC.U
367
DELISTED
VPC Impact Acquisition Holdings III, Inc. Units, each consisting of one share of Class A common stoc
VPCC.U
-400,000
Closed -$3.95M
DCRCU
368
DELISTED
Decarbonization Plus Acquisition Corporation III Unit
DCRCU
-2,000,000
Closed -$19.9M
RTPYU
369
DELISTED
Reinvent Technology Partners Y Unit
RTPYU
-750,000
Closed -$7.53M
KURIU
370
DELISTED
Alkuri Global Acquisition Corp Unit
KURIU
-400,000
Closed -$3.95M
SRNGU
371
DELISTED
Soaring Eagle Acquisition Corp. Unit
SRNGU
-500,000
Closed -$5.06M
CMIIU
372
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
-250,000
Closed -$3.2M
CNST
373
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
-1,000,000
Closed -$23.4M
PRAH
374
DELISTED
PRA Health Sciences, Inc.
PRAH
-350,000
Closed -$53.7M
TBA
375
DELISTED
Thoma Bravo Advantage
TBA
-500,000
Closed -$5.22M

Similar funds

Thomas Steyer's Q2 2021 Portfolio in Review

As of Q2 2021, Thomas Steyer held 397 positions worth $24.5B, up 22% from $20.1B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Thomas Steyer deployed $2.47B of net new capital in Q2 2021, opening 164 new positions and adding to 36 existing holdings. Its largest new stake was Nuance Communications, Inc.: 7,337,500 shares worth $399M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $456M trimmed.

  • Thomas Steyer's largest Q2 2021 buy was Nuance Communications, Inc.: 7,337,500 shares worth $399M.
  • Thomas Steyer added most to Alexion Pharmaceuticals in Q2 2021, an estimated $332M increase.
  • Thomas Steyer's biggest Q2 2021 reduction was Alphabet (Google) Class C, cutting an estimated $456M.
  • Thomas Steyer fully exited INPHI CORPORATION in Q2 2021, selling an estimated $311M.
  • Thomas Steyer's ten largest holdings make up 39% of its $24.5B portfolio in Q2 2021.
  • Thomas Steyer opened 164 new positions and closed 100 in Q2 2021.
  • Thomas Steyer's portfolio value rose 22% quarter-over-quarter to $24.5B.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.